CECAP

Blumenau 89035-510

1 studies enrolling now · 1 studies all time

What they study most

Gastroesophageal Junction Adenocarcinoma, Metastatic Gastric Adenocarcinoma

Studies at this site

• A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now